Join the Ozempic group to help and get support from people like you.
Ozempic News (Page 10)
Ozempic, Mounjaro Help People With Type 1 Diabetes Control Blood Sugar, Lose Weight
FRIDAY, Sept. 13, 2024 – Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study...
Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide
FRIDAY, Sept. 13, 2024 – For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent, dosage, treatment indication, and...
Ozempic or Saxenda for Weight Loss: Which Works Best?
FRIDAY, Sept. 13, 2024 – Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new...
Ozempic Can Prevent Heart Trouble in Folks With Kidney Issues
THURSDAY, Sept. 12, 2024 – Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ a...
Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection
MONDAY, Sept. 9, 2024 – A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study...
Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection
MONDAY, Sept. 9, 2024 – A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study...
Semaglutide Does Not Increase Psychiatric Complications in Overweight, Obesity
TUESDAY, Sept. 3, 2024 – Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior among adults with overweight or obesity, according...
Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds
TUESDAY, Sept. 3, 2024 – The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study rules...
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find
FRIDAY, Aug.30, 2024 – New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. These two injected drugs are versions of...
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure
WEDNESDAY, Aug. 28, 2024 – Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or...
After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide
MONDAY, Aug. 26, 2024 – Increases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of Internal Medicine. After the Semaglutide Effects on...
Semaglutide-Linked Suicidal Ideation ID'd in Disproportionality Analysis
WEDNESDAY, Aug. 21, 2024 – Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open. Georgios...
GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 Diabetes
MONDAY, Aug. 12, 2024 – Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin system inhibitor...
Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds
WEDNESDAY, Aug. 7, 2024 (HealthDay news) – Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds. Medicaid...
2021 to 2023 Saw Considerable Increase in Semaglutide Fills
MONDAY, Aug. 5, 2024 – From 2021 through 2023, there was a considerable increase in the number of semaglutide fills, according to a research letter published online Aug. 2 in JAMA Health Forum....
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Chronic Kidney Disease, Cardiovascular Risk Reduction, Diabetes, Type 2